Support teaching, research, and patient care.
Development of an artificial heart assist device; heart, and heart-lung transplantation.
The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial Not Recruiting
The purpose of this study is to determine the safety and effectiveness of the HeartWare Ventricular Assist System in patients with chronic Stage D/ New York Heart Association (NYHA) Class IIIB/IV left ventricular failure who have received and failed optimal medical therapy, and who are ineligible for cardiac transplantation.
Stanford is currently not accepting patients for this trial. For more information, please contact Philip Oyer, (650) 725-3820.
View full details